# Gossamer Bio, Inc. (GOSS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Gossamer Bio, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/GOSS/mda/fy2025/): filed 2026-03-17; accession 0001728117-26-000017 (https://www.sec.gov/Archives/edgar/data/1728117/000172811726000017/goss-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/GOSS/mda/fy2024/): filed 2025-03-13; accession 0001728117-25-000021 (https://www.sec.gov/Archives/edgar/data/1728117/000172811725000021/goss-20241231.htm)
- [FY 2023 MD&A](/company/GOSS/mda/fy2023/): filed 2024-03-05; accession 0001728117-24-000019 (https://www.sec.gov/Archives/edgar/data/1728117/000172811724000019/goss-20231231.htm)
- [FY 2022 MD&A](/company/GOSS/mda/fy2022/): filed 2023-03-17; accession 0001728117-23-000010 (https://www.sec.gov/Archives/edgar/data/1728117/000172811723000010/goss-20221231.htm)
- [FY 2021 MD&A](/company/GOSS/mda/fy2021/): filed 2022-03-03; accession 0001728117-22-000019 (https://www.sec.gov/Archives/edgar/data/1728117/000172811722000019/goss-20211231.htm)

Back to /company/GOSS/